SCHEMBL6269292

SCHEMBL6269292

NN1CCCCC(=O)C1=S(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1278075 0.67 — —
SCHEMBL12802250 0.66 — —
SCHEMBL7380304 0.66 BRD4 (0.39) —
SCHEMBL874304 0.66 — —
Hydrochloric Acid SCHEMBL909236 0.66 — —
SCHEMBL25124370 0.66 BRD4 (0.39) —
Hydrochloric Acid SCHEMBL11837161 0.64 ALDH1A1 (0.37) —
Bromide SCHEMBL27801925 0.64 ALDH1A1 (0.37) —
SCHEMBL981790 0.59 — —
SCHEMBL33935 0.58 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005013909-A3 NOVEL CATHEPSIN K INHIBITORS SMITHKLINE BEECHAM CORP (US) 2005-08-18 — — WO disclosed
WO-2005013909-A2 NOVEL CATHEPSIN K INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2005-02-17 — — WO disclosed
WO-2005013909-A2 NOVEL CATHEPSIN K INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2005-02-17 — — WO disclosed
Send feedback